Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase
Resolution Therapeutics raised $29147914 on 2024-10-03 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …
OFF
Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase
6 days from now
Resolution Therapeutics raised $29147914 on 2024-10-03 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. …
crunchbase.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Resolution raises £63.5M series B financing from Syncona and appoints Paul Sekhri as Chair of the Board of Directors. ... Edinburgh and London, UK, 3 October 2024 – Resolution …
resolution-tx.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 03, 2024, 02:30 ET. Share this article ... has raised £63.5 million in Series B ... and is expected to initiate patient recruitment in the fourth quarter of 2024. About Resolution …
prnewswire.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · EMERALD, Resolution's first-in-human Phase I/II clinical trial, will be conducted in the UK and Spain and is anticipated to initiate patient recruitment in Q4 2024. Additional uses …
yahoo.com
OFF
Resolution Therapeutics Raises £63.5 Million In Series B Financing …
6 days from now
Oct 3, 2024 · Syncona’s £63.5 million Series B commitment will be used by Resolution to progress the company and advance its lead candidate, RTX001 in end-stage liver …
pharmiweb.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …
streetinsider.com
OFF
Resolution Therapeutics Announces £63.5 Million Series B …
6 days from now
Oct 3, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …
optimumcomms.com
OFF
Resolution Therapeutics Announces Approval Of Clinical Trial ...
6 days from now
3 days ago · Resolution Therapeutics Announces £63.5 Million Series B Financing and Chair Appointment . Resolution Therapeutics Limited ("Resolution"), a clinical-stage …
prnewswire.com
OFF
London Stock Exchange | London Stock Exchange
6 days from now
3 October 2024 . Syncona Limited . Resolution Therapeutics raises £63.5 million in Series B financing and appoints new Chair · Syncona's £63.5 million Series B commitment will be used …
londonstockexchange.com
OFF
Resolution Therapeutics Scores £63.5 Million In Series B Round
6 days from now
Oct 3, 2024 · UK-based biotech Resolution Therapeutics has raised £63.5 million ($76.8 million) in a series B round led by Syncona to advance its macrophage therapy, RTX001, into clinical …
thepharmaletter.com
OFF
Resolution Therapeutics Raises £63.5M In Series B Financing
6 days from now
Oct 3, 2024 · Resolution Therapeutics, an Edinburgh, Scotland, and London, UK-based clinical-stage biopharmaceutical company, raised £63.5M in Series B funding.. The round was led by …
finsmes.com
OFF
Series A - Resolution Therapeutics - 2022-04-05 - Crunchbase
6 days from now
Apr 5, 2022 · Resolution Therapeutics raised $13076904 on 2022-04-05 in Series A. Syncona Partners LLP Syncona Partners LLP is a healthcare company focused on investing in and …
crunchbase.com
OFF
Resolution Therapeutics Announces A £10m Extended Series A …
6 days from now
Apr 5, 2022 · – Broadening research pipeline into allogeneic macrophages for the treatment of liver disease – London, 5 April 2022 – Resolution Therapeutics Limited (“Resolution”), a …
resolution-tx.com
OFF
Series A - Resolution Therapeutics - 2020-12-02 - Crunchbase
6 days from now
Dec 2, 2020 · Resolution Therapeutics raised $35559881 on 2020-12-02 in Series A. Syncona Partners LLP Syncona Partners LLP is a healthcare company focused on investing in and …
crunchbase.com
OFF
Series B - Purespring Therapeutics - 2024-10-09 - Crunchbase
6 days from now
Oct 9, 2024 · Purespring Therapeutics raised $104711631 on 2024-10-09 in Series B. Sofinnova Partners Sofinnova Partners is a venture capital firm that invests in the life sciences sector, …
crunchbase.com
OFF
Series B - Terray Therapeutics - 2024-10-17 - Crunchbase
6 days from now
Oct 17, 2024 · Terray Therapeutics raised $120000000 on 2024-10-17 in Series B. Bedford Ridge Capital Bedford Ridge Capital is a private equity firm that focuses on financial advisory services.
crunchbase.com
OFF
Series B - CorFlow Therapeutics AG - 2024-09-10 - Crunchbase
6 days from now
Sep 10, 2024 · CorFlow Therapeutics AG raised $48578955 on 2024-09-10 in Series B. Search Crunchbase. Start Free Trial ... Organization Name . CorFlow Therapeutics AG . Announced …
crunchbase.com
FAQs about Series B - Resolution Therapeutics - 2024-10-03 - Crunchbase Coupon?
Is resolution a regenerative biopharmaceutical company?
What is resolution Therapeutics?
Is Resolution a company owned by Syncona?
What does Series A funding mean for Resolution?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
